ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.
ICMR-National Institute for Research in Tuberculosis, Chennai, India.
PLoS One. 2024 Jul 16;19(7):e0305855. doi: 10.1371/journal.pone.0305855. eCollection 2024.
By encouraging treatment adherence and lowering mortality, dietary supplements can serve as adjuvant therapy for the success of medical interventions. We determined the effect of locally accessible food supplements on treatment outcomes, and health-related quality of life in patients with pulmonary tuberculosis initiating anti-tuberculosis treatment (ATT) in Odisha, India.
Between September 2017 and December 2018, implementation research in patients with newly diagnosed sputum smear-positive pulmonary tuberculosis initiating ATT in five districts of the tribal belt of Odisha, offered food supplements along with ATT in a phased manner. Clinical symptoms, anthropometry, sputum for M. tuberculosis (M. tb), health-related quality of life and return to normal function were assessed periodically, and favourable treatment outcome (cure or treatment completed) was measured at the end of treatment. The effect of the food supplement on unfavorable outcomes (treatment failure, death, or lost-to-follow-up) was modelled using mixed-effects Poisson regression to determine the risk factors.
Among the 761 participants enrolled, 614 participants received the food supplement and 147 did not receive the food supplement. Among the 614 participants in the supplement group, 537 (87%) had a favorable outcome and among the 147 participants in the no-supplement group, 113 (77%) had a favorable outcome (p = 0.0017). Higher age (>55 years) [aRR = 2.1(95% CI: 1.1-3.8)], male gender [aRR = 1.7(95% CI: 1.2-2.9)], and smear grading ≥2+ [aRR = 1.5 (95% CI: 1.1-2.2)] were associated with unfavorable treatment outcomes. Nutritional status, quality of life and lung health showed significant improvement from baseline in the supplement group.
Improvement in the nutritional status of the patient can be considered a predictor of treatment success rates. Early food supplementation has a positive impact on the nutritional status.
通过鼓励治疗依从性和降低死亡率,膳食补充剂可以作为医学干预成功的辅助治疗。我们在印度奥里萨邦五个部落地区的新诊断为痰涂片阳性肺结核患者中,确定了局部可获得的食物补充剂对治疗结果和与健康相关的生活质量的影响。
在 2017 年 9 月至 2018 年 12 月期间,对开始抗结核治疗(ATT)的新诊断为痰涂片阳性肺结核患者进行实施研究,在分阶段提供 ATT 的同时提供食物补充剂。定期评估临床症状、人体测量学、结核分枝杆菌(M. tb)痰、与健康相关的生活质量和恢复正常功能,在治疗结束时测量有利的治疗结果(治愈或完成治疗)。使用混合效应泊松回归模型来确定食物补充剂对不良结局(治疗失败、死亡或失访)的影响,以确定危险因素。
在纳入的 761 名参与者中,614 名参与者接受了食物补充剂,147 名参与者未接受食物补充剂。在补充组的 614 名参与者中,537 名(87%)有良好的结局,在没有补充组的 147 名参与者中,113 名(77%)有良好的结局(p = 0.0017)。较高的年龄(>55 岁)[ARR = 2.1(95%CI:1.1-3.8)]、男性性别[ARR = 1.7(95%CI:1.2-2.9)]和涂片分级≥2+[ARR = 1.5(95%CI:1.1-2.2)]与不良治疗结局相关。补充组的营养状况、生活质量和肺部健康从基线开始有显著改善。
患者营养状况的改善可以被认为是治疗成功率的预测因素。早期食物补充对营养状况有积极影响。